Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Melatonin Replacement for Treatment of Sleep Disruption.

Trial Profile

Melatonin Replacement for Treatment of Sleep Disruption.

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Aug 2018

At a glance

  • Drugs Ramelteon (Primary)
  • Indications Sleep disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 22 Jun 2011 Planned end date changed from 1 May 2011 to 1 Jul 2011 as reported by ClinicalTrials.gov.
    • 05 Jan 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top